Geode Capital Management »

Phathom Pharmaceuticals shares owned by Geode Capital Management

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 863k 18.08
2024-06-30 $8.3M 806k 10.30
2024-03-31 $8.0M 751k 10.62
2023-09-30 $7.1M 683k 10.37
2023-06-30 $7.0M 490k 14.32
2023-03-31 $3.2M 449k 7.14
2022-12-31 $4.9M 435k 11.22
2022-09-30 $4.5M 402k 11.08
2022-06-30 $2.9M 347k 8.44
2022-03-31 $4.3M 314k 13.61
2021-12-31 $5.8M 293k 19.67
2021-09-30 $9.1M 284k 32.10
2021-06-30 $9.5M 281k 33.85
2021-03-31 $7.9M 210k 37.56
2020-12-31 $5.9M 178k 33.22
2020-09-30 $6.7M 182k 36.67
2020-06-30 $5.9M 178k 32.91
2020-03-31 $4.2M 161k 25.82
2019-12-31 $4.8M 153k 31.13